MUC1 and MUC16: critical for immune modulation in cancer therapeutics.
Saved in:
| Title: | MUC1 and MUC16: critical for immune modulation in cancer therapeutics. |
|---|---|
| Authors: | Chen X; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China., Sandrine IK; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China., Yang M; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China., Tu J; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China., Yuan X; Department of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China. |
| Source: | Frontiers in immunology [Front Immunol] 2024 Feb 01; Vol. 15, pp. 1356913. Date of Electronic Publication: 2024 Feb 01 (Print Publication: 2024). |
| Publication Type: | Journal Article; Review; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1664-3224 |
|---|---|
| DOI: | 10.3389/fimmu.2024.1356913 |
